| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.58 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |